EVOLISBLIND LTD

Company number 14568396 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

EVOLISBLIND LTD - Analysis Report

Company Number: 14568396

Analysis Date: 2025-07-20 15:18 UTC

Financial Health Assessment for EVOLISBLIND LTD


1. Financial Health Score: B

Explanation:
As a newly incorporated micro-entity, EVOLISBLIND LTD shows a solid starting position with positive net current assets and shareholders’ funds. The absence of liabilities beyond current obligations and a clean balance sheet indicates a "healthy pulse" at this early stage. However, the lack of turnover and employees reflects a very early developmental phase, limiting a full "A" grade until operational activity and profitability are demonstrated.


2. Key Vital Signs (Core Financial Metrics)

Metric Value Interpretation
Current Assets £14,426 Adequate short-term resources available.
Current Liabilities £3,313 Manageable immediate debts.
Net Current Assets £11,113 Positive working capital – “healthy cash flow buffer.”
Total Net Assets £11,114 Company equity represents solid foundation.
Shareholders’ Funds £11,114 Fully funded by owner’s equity; no debt.
Number of Employees 0 No staff employed yet – early stage setup.
Account Category Micro Limited financial complexity, minimal filing.

3. Diagnosis: What the Financial Data Reveals About Business Health

EVOLISBLIND LTD is in the very early infancy of its business lifecycle, having been incorporated in January 2023 with first accounts filed for the period ending January 2024. The company shows symptoms of financial stability: positive net current assets and no outstanding long-term liabilities imply no immediate financial distress. The presence of shareholder funds equal to net assets suggests the business is fully equity-financed, reducing risk from creditors at this stage.

However, the absence of employees and no reported revenue or profit figures in the micro-entity accounts suggests the company is not yet fully operational or generating trading income. This is common for startups in their initial year but flags the need for monitoring operational progress in subsequent periods.

The director, who is also the sole significant controller, demonstrates centralized governance which can be efficient but may also present risks if dependent on a single individual for management and financial decisions.


4. Recommendations: Specific Actions to Improve Financial Wellness

  • Operational Kickoff and Revenue Generation:
    The primary focus should be on starting or scaling business operations to generate revenue and build profit reserves. This will improve the company's financial vitality and provide "nutrients" for sustainable growth.

  • Cash Flow Management:
    Maintain positive net current assets by closely monitoring cash inflows and outflows. Avoid overextending liabilities, as early-stage companies are vulnerable to cash shortages.

  • Build a Financial Forecast:
    Develop a simple budget and cash flow forecast to anticipate funding needs, operational expenses, and break-even timelines. This diagnostic tool helps detect early warning signs ("symptoms") of financial stress.

  • Consider Adding Staff or Outsourcing:
    If growth plans require, consider hiring or contracting staff to support business functions. This will impact costs but is essential for scaling operations.

  • Governance and Controls:
    As the sole director and shareholder, consider documenting key decisions and maintaining clear accounting records. This builds transparency and reduces risks of operational oversight.

  • Plan for Next Filing Deadlines:
    Ensure timely submission of annual accounts and confirmation statements to avoid penalties and maintain good standing.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.